Study Comparing Ivonescimab Alone or Ivonescimab in Combination With Ligufalimab Versus Pembrolizumab for the Treatment of SCCHN

Name: Study Comparing Ivonescimab Alone or Ivonescimab in Combination With Ligufalimab Versus Pembrolizumab for the Treatment of SCCHN
License: Public Domain

Groupe Oncologie Radiotherapie Tete et Cou

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

squamous cell carcinoma head and neck cancer (hnscc)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 332739
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.